Harrow Health, Inc.HROWNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+90.1%
5Y CAGR+54.1%
Year-over-Year Change
Research and development spending
3Y CAGR
+90.1%/yr
vs +38.7%/yr prior
5Y CAGR
+54.1%/yr
Recent acceleration
Acceleration
+51.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
8.7x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $20.94M | +71.2% |
| 2024 | $12.23M | +83.9% |
| 2023 | $6.65M | +118.1% |
| 2022 | $3.05M | -72.5% |
| 2021 | $11.08M | +359.3% |
| 2020 | $2.41M | +15.8% |
| 2019 | $2.08M | +152.5% |
| 2018 | $825000.00 | +99.8% |
| 2017 | $413000.00 | -44.1% |
| 2016 | $739000.00 | - |